Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2641
H.R.2641: Promoting Life-Saving New Therapies for Neonates Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced May 24, 2017
- Latest Major Action May 26, 2017
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
37 (23 Democrats, 14 Republicans)
Bill Version
- Introduced in House - May 24, 2017
Bill Summary
Promoting Life-Saving New Therapies for Neonates Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to award the sponsor of a new drug or biological product for the treatment of newborns a neonatal drug exclusivity voucher upon approval of the medication. A neonatal drug exclusivity voucher is a transferable voucher for a one-year extension of all existing patents and...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
May 26, 2017 |
Referred to the Subcommittee on Health.
|
May 24, 2017 |
Referred to the House Committee on Energy and Commerce.
|
May 24, 2017 |
Introduced in the House by Billy Long (R-Mo.) |